FIELD: medicine.
SUBSTANCE: group of inventions relates to therapy, namely to pulmonology, and can be used for suppressing bacteria Pseudomonas aeruginosa, growing in anaerobic conditions, as well as for the treatment of the pulmonary bacterial infection, caused by them. For this purpose an effective quantity of an aerosol of a fluoroquinolone antibiotic, selected from the group, consisting of levofloxacin and ofloxacin, in a concentration of 0.125-0.128 mg/l is introduced.
EFFECT: application of the claimed inventions makes it possible to influence the said bacteria with the quantity of the fluoroquinolone antibiotic, effective of their growth suppression.
22 cl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMBINED COMPOSITION FOR THE TREATMENT OF PURULENT WOUNDS ON THE BASIS OF FLUOROQUINOLONS (OPTIONS) | 2016 |
|
RU2682171C2 |
| USING LEVOFLOXACIN IN AEROSOL FORM FOR TREATING MUCOVISCIDOSIS | 2010 |
|
RU2563809C2 |
| TRIASOL COMPOUNDS FOR TREATMENT OF BIOFILM FORMATION | 2008 |
|
RU2478385C2 |
| COMPOSITION AND METHOD OF PRODUCING EYE DROPS | 2014 |
|
RU2595837C2 |
| CEFTAROLINE-INCLUDING COMPOSITIONS AND METHODS OF TREATMENT | 2009 |
|
RU2524665C2 |
| AEROSOL FLUOROCHINOLONES AND THEIR APPLICATIONS | 2006 |
|
RU2428986C2 |
| OPHTHALMIC OINTMENT FORMULATION AND METHOD FOR PREPARING SAME | 2012 |
|
RU2531937C2 |
| AEROSOLIZED FLUOROQUINOLONES AND USES THEREOF | 2006 |
|
RU2603638C2 |
| PHARMACEUTICAL COMBINED COMPOSITION FOR LOCAL AND EXTERNAL USE ON BASIS OF BACTERIOLYTIC AND PROTEOLYTIC COMPLEX OF ENZYMES | 2016 |
|
RU2655808C2 |
| ANTIBACTERIAL PHARMACEUTICAL COMPOSITION FOR TREATMENT OF FARM ANIMALS AND POULTRY | 2015 |
|
RU2570389C1 |
